Article Sidebar

pdf
Date Published: 15/02/2024
Abstract Views: 428
Views pdf: 135
DOI: https://doi.org/10.51298/vmj.v535i1B.8424
Issue
Vol. 535 No. 1B (2024)
Section
Các bài báo
How to Cite
Lê, H., & Tống, T. K. H. (2024). RESULTS OF TRANSTHORACIC NEEDLE BIOPSY IN PATIENTS WITH LUNG NODULES CLASSIFIED LUNG – RADS 4 ACCORDING TO ACR 2019. Vietnam Medical Journal, 535(1B). https://doi.org/10.51298/vmj.v535i1B.8424

RESULTS OF TRANSTHORACIC NEEDLE BIOPSY IN PATIENTS WITH LUNG NODULES CLASSIFIED LUNG – RADS 4 ACCORDING TO ACR 2019

Hoàn Lê, Thị Khánh Hòa Tống

Main Article Content

Abstract

Lung-RADS classification on chest computed tomography aids in stratifying the risk of cancer with lung nodules. Objective: Describe the clinical characteristics, chest computed tomography images and histopathological results of lung nodules classified as Lung-RADs 4. Research subjects and methods: Cross-sectional descriptive study was conducted on 104 patients with lung nodules classified Lung-RADs 4 who underwent transthoracic needle biopsy. Results: Lung nodules are most common in the right upper lobe with a rate of 43,3%; nodules size ≥15 mm account for 76%; nodules < 15 mm account for 24%; solid nodules account for 92,3% and semi-solid nodules account for 7,7%; malignant and benign histopathology was 66% and 34%. Conclusion: Common computed tomography imaging features in malignant lung nodules are size ≥ 15mm, irregular borders and solid nodules. The rate of malignant nodules gradually increases according to the cancer risk of the Lung-RADS classification (2019).

Article Details

Keywords

lung nodules, chest computed tomography, lung cancer.

References

1. Huang P, Lin C.T, Li Y, et al. Prediction of lung cancer risk at followup screening with low-dose CT: a training and validation study of a deep learning method. Lancet Digit Heal, 2019 Nov;1(7):e353-e362. DOI: 10.1016/S2589-7500(19)30159-1..
2. Kanwal M, Ding X.J, and Cao Y. Familial risk for lung cancer. Oncol Lett, 2017 Feb;13(2):535-542. doi: 10.3892/ol.2016.5518.
3. Ost D. Approach to the patient with Pulmonary nodules. Fishman’s Pulmonary Diseases and Disorders. 5th edition, McGraw-Hill Education, 3348-3378
4. Triphuridet N. and Henschke C. Landscape on CT screening for lung cancer in Asia. Lung Cancer Targets Ther, 10: 107-124. DOI: 10.2147/LCTT.S192643
5. American Lung Association. Providing Guidance on Lung Cancer Screening to Patients and Physicians. 2012.
6. De Koning H.J, Van Der Aalst C.M, De Jong P.A, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med . 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793
7. Wood D.E, Kazerooni E.A, Baum S.L, et al. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 Apr;16(4):412-441. doi: 10.6004/jnccn.2018.0020.
8. American College of Radiology. Lung‐ RADS ® Version 1.1 Assessment categories 3, 2019.
9. Cardillo G., Regal M., Sera F. et al. Videothoracos management of the solitary pulmonary nodule: a single institution study on 429 cases. Ann Thorac Surg. 2003 May;75(5):1607-11; discussion 1611-2. doi: 10.1016/s0003-4975(02)04827-0.
10. Lê Hoàn, Vũ Văn Giáp, Lê Minh Hằng và cộng sự. Chẩn đoán căn nguyên nốt đơn độc ở phổi tại Bệnh viện Đại học Y Hà Nội, Tạp chí nghiên cứu Y học, 147 (11): 123-130